Bioforce USA Is Pleased Dr. Oz Loves Arnica Gel
AmericaÃ¢s Doctor, Dr. Oz, Demonstrated Using Arnica Gel for Soothing Knees on the October 19th Dr. Oz Show
Ghent, NY (PRWEB) October 29, 2011
According to Bioforce USA, Dr. Oz stated on his program that achy joints, sore feet, and knees are common as we get older. For joint comfort Dr. Oz recommends Arnica Gel. He demonstrated rubbing arnica gel into the knee for soothing, and then wrapping the knee for stabilizing.
Arnica been used traditionally for hundreds of years Arnica has moved from the realm of traditional remedy to a research backed herbal product. There are currently two published clinical studies, one in Advances in Therapy and one in Rheumatol Int. Both studies used a specific herbal Arnica product from the famous Swiss herbal company, Bioforce that produces A. Vogel Arnica Rub.
Arnica been used traditionally for hundreds of years. Now according to Pierce Sioussat, President of Bioforce USA, Ã¢Å“Arnica has moved from the realm of traditional remedy to a research backed herbal product. We are happy that Dr. Oz recognizes and promotes the benefits of this special flower of the daisy family. We believe that Arnica Gel belongs in every home because of its ability to improve comfort and wellbeing.Ã¢
A. Vogel Arnica Rub is unique in that it delivers the full power of nature to aching joints. The product formulation consists of an unusually rich supply of certified, organically grown Arnica flowers. In fact, each tube of A. Vogel Arnica Rub contains approximately 20 flowers.
About Bioforce USA
Bioforce USA has created long-term strategic alliances with European manufacturers of product lines that have years of clinical research support for safety and efficacy, plus years of repeat consumer use. Bioforce USA has brought these lines, which include A. Vogel, Sanhelios, Herbatint, Bionorica and SECURE exclusively to the United States for distribution through natural products and health food stores.
For more information call Eileen Sheets at 800-641-7555 x100.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/10/prweb8915603.htm